Analysts See $0.80 EPS for Zoetis Inc. (ZTS); Clorox Company (the (CLX) Shorts Lowered By 0.07%

The Clorox Company (NYSE:CLX) Logo

Clorox Company (the (NYSE:CLX) had a decrease of 0.07% in short interest. CLX’s SI was 7.94M shares in April as released by FINRA. Its down 0.07% from 7.95 million shares previously. With 1.30M avg volume, 6 days are for Clorox Company (the (NYSE:CLX)’s short sellers to cover CLX’s short positions. The SI to Clorox Company (the’s float is 6.21%. The stock increased 0.49% or $0.74 during the last trading session, reaching $153.08. About 482,063 shares traded. The Clorox Company (NYSE:CLX) has risen 21.73% since April 17, 2018 and is uptrending. It has outperformed by 17.36% the S&P500. Some Historical CLX News: 07/05/2018 – Former CFO Centered Clorox’s Business on the Domestic Market; 30/03/2018 – Clorox CFO Steve Robb Previously Planned to Continue in Advisory Capacity Until June 30, 2018; 27/03/2018 – FTC: 20180921: The Clorox Company; HPH Specialized International Fund 1, LP; 02/05/2018 – Clorox: Affected by Industrywide Cost Pressures in Near Term; 12/03/2018 – Clorox Estimates Nutranext Acquisition Will Dilute FY19 EPS by 8-12 Cents; 18/05/2018 – At a valuation of $16 billion, that makes the India business worth more than 170 companies in the S&P 500 including Clorox, Macy’s and Tiffany & Co; 12/03/2018 – Moody’s Says Clorox’s Announced Acquisition Of Nutranext Is Credit Negative, But Ratings Not Affected; 02/05/2018 – Clorox 3Q EPS $1.37; 02/05/2018 – Clorox Beats Profit Expectations, But Margins Fall On Higher Commodity And Logistics Costs — MarketWatch; 15/03/2018 – Cramer also sits down with the CEOs of Intel, HP Inc. and Clorox

Analysts expect Zoetis Inc. (NYSE:ZTS) to report $0.80 EPS on May, 1.They anticipate $0.05 EPS change or 6.67% from last quarter’s $0.75 EPS. ZTS’s profit would be $383.32M giving it 30.56 P/E if the $0.80 EPS is correct. After having $0.79 EPS previously, Zoetis Inc.’s analysts see 1.27% EPS growth. The stock decreased 1.24% or $1.23 during the last trading session, reaching $97.78. About 1.58 million shares traded. Zoetis Inc. (NYSE:ZTS) has risen 19.18% since April 17, 2018 and is uptrending. It has outperformed by 14.81% the S&P500. Some Historical ZTS News: 16/05/2018 – ZOETIS TO BUY ABAXIS BUY PRICE OF US $83/SHR IN CASH; 05/04/2018 – ZOETIS INC ZTS.N : CREDIT SUISSE RAISES TARGET PRICE TO $89 FROM $83; RATING OUTPERFORM; 16/05/2018 – Zoetis to Buy Diagnostics Company Abaxis in $2 Billion Cash Deal; 02/05/2018 – ZOETIS 1Q REV. $1.4B, EST. $1.35B; 16/05/2018 – ABAXIS – DEAL AGREEMENT ALSO PROVIDES THAT TERMINATION FEE OF $120 MLN MAY BE PAYABLE BY ZOETIS TO THE COMPANY UNDER OTHER SPECIFIED CIRCUMSTANCES; 26/04/2018 – Zoetis to Expand Animal Vaccine Research and Manufacturing in Suzhou, China; 16/05/2018 – ZOETIS SEES DEAL IMPACTING 2018 REPORTED EARNINGS; 29/03/2018 – Zoetis to Host Webcast and Conference Call on First Quarter 2018 Financial Results; 16/05/2018 – ZOETIS – EXPECTS DEAL TO HAVE IMPACT ON 2018 EARNINGS RELATED TO CUSTOMARY CLOSING ACTIVITIES; ON ADJUSTED BASIS, CO DOES NOT EXPECT MATERIAL IMPACT; 16/05/2018 – Zoetis to Buy Veterinary-Diagnostics Company Abaxis for $2 Billion

Among 6 analysts covering Zoetis (NYSE:ZTS), 3 have Buy rating, 0 Sell and 3 Hold. Therefore 50% are positive. Zoetis had 9 analyst reports since November 2, 2018 according to SRatingsIntel. Cantor Fitzgerald maintained the shares of ZTS in report on Thursday, February 14 with “Buy” rating. Credit Suisse maintained the shares of ZTS in report on Tuesday, April 2 with “Outperform” rating. The company was initiated on Wednesday, March 20 by UBS. SunTrust initiated Zoetis Inc. (NYSE:ZTS) rating on Tuesday, March 19. SunTrust has “Hold” rating and $100 target. The rating was maintained by BMO Capital Markets on Monday, February 25 with “Market Perform”. The firm earned “Hold” rating on Friday, February 22 by BMO Capital Markets. JP Morgan maintained the shares of ZTS in report on Friday, November 2 with “Overweight” rating.

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines and vaccines for livestock and companion animals in the United States and internationally. The company has market cap of $46.85 billion. It offers anti-infectives that prevent, kill, or slow the growth of bacteria, fungi, or protozoa; vaccines, which are biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts or induce a specific immune response; and parasiticides that prevent or eliminate external and internal parasites, such as fleas, ticks, and worms. It has a 33.37 P/E ratio. The firm also provides medicated feed additives that offer medicines to livestock; and other pharmaceutical products, including pain and sedation, oncology, antiemetic, allergy and dermatology, and reproductive products.

Since November 8, 2018, it had 0 buys, and 7 insider sales for $17.15 million activity. Lewis Clinton A. Jr. also sold $563,255 worth of Zoetis Inc. (NYSE:ZTS) on Thursday, February 14. 2,500 shares valued at $233,775 were sold by Chen Heidi C. on Monday, December 3. The insider Alaix Juan Ramon sold $14.27 million. Reed Willie M sold $300,437 worth of Zoetis Inc. (NYSE:ZTS) on Friday, November 30. Shares for $1.09 million were sold by PECK KRISTIN C. $170,600 worth of Zoetis Inc. (NYSE:ZTS) shares were sold by Lagano Roxanne.

More news for Zoetis Inc. (NYSE:ZTS) were recently published by: Investorplace.com, which released: “5 of the Best Dow Jones Stocks to Buy for Solid Dividends – Investorplace.com” on March 20, 2019. Benzinga.com‘s article titled: “Daily Biotech Pulse: FDA Nod For ADMA, Regulatory Setback For Apyx, Achieve Life Sciences Smoking Cessation Drug Trial – Benzinga” and published on April 02, 2019 is yet another important article.

Investors sentiment increased to 1.03 in 2018 Q4. Its up 0.05, from 0.98 in 2018Q3. It is positive, as 44 investors sold Zoetis Inc. shares while 282 reduced holdings. 88 funds opened positions while 249 raised stakes. 425.68 million shares or 4.24% more from 408.35 million shares in 2018Q3 were reported. Fred Alger Mngmt stated it has 5,353 shares or 0% of all its holdings. Bradley Foster Sargent Ct holds 0.91% or 264,931 shares in its portfolio. Associated Banc holds 62,435 shares or 0.35% of its portfolio. Gulf Intll Fincl Bank (Uk) accumulated 114,872 shares or 0.19% of the stock. Pub Employees Retirement Sys Of Ohio accumulated 0.17% or 341,269 shares. Fort Washington Invest Advsr Oh owns 197,980 shares or 0.21% of their US portfolio. Hightower Advisors Ltd Com holds 381,009 shares or 0.25% of its portfolio. Pennsylvania-based Janney Montgomery Scott Limited has invested 0.1% in Zoetis Inc. (NYSE:ZTS). Gamco Investors Et Al has 0.16% invested in Zoetis Inc. (NYSE:ZTS). Leonetti & Assoc Ltd Llc has 3.97% invested in Zoetis Inc. (NYSE:ZTS). Laurion Mgmt L P reported 61,857 shares. Sunbelt Securities Incorporated owns 4,250 shares or 0.21% of their US portfolio. Hwg Holding Limited Partnership invested 0% in Zoetis Inc. (NYSE:ZTS). Marietta Prtn Ltd Liability owns 31,742 shares. Chesley Taft Associates Ltd invested 0.19% of its portfolio in Zoetis Inc. (NYSE:ZTS).

Among 6 analysts covering Clorox (NYSE:CLX), 2 have Buy rating, 2 Sell and 2 Hold. Therefore 33% are positive. Clorox had 10 analyst reports since November 1, 2018 according to SRatingsIntel. Citigroup maintained The Clorox Company (NYSE:CLX) rating on Tuesday, November 20. Citigroup has “Neutral” rating and $169 target. The firm has “Sell” rating by Deutsche Bank given on Wednesday, March 20. The rating was downgraded by JP Morgan on Monday, April 8 to “Underweight”. The stock has “Sell” rating by Deutsche Bank on Thursday, November 1. The firm has “Hold” rating given on Thursday, February 21 by Wells Fargo. Citigroup maintained The Clorox Company (NYSE:CLX) on Friday, November 2 with “Neutral” rating. BMO Capital Markets maintained it with “Outperform” rating and $165 target in Friday, November 2 report. The rating was maintained by Wells Fargo with “Market Perform” on Wednesday, December 12.

More notable recent The Clorox Company (NYSE:CLX) news were published by: Investorplace.com which released: “3 Out-of-Favor Consumer Stocks to Buy – Investorplace.com” on March 20, 2019, also Benzinga.com with their article: “Benzinga’s Top Upgrades, Downgrades For April 8, 2019 – Benzinga” published on April 08, 2019, Benzinga.com published: “10 Biggest Price Target Changes For Monday – Benzinga” on April 08, 2019. More interesting news about The Clorox Company (NYSE:CLX) were released by: Bizjournals.com and their article: “Clorox sues Lysol maker over mudslinging in the cleaning aisle – San Francisco Business Times – San Francisco Business Times” published on March 20, 2019 as well as 247Wallst.com‘s news article titled: “Top Analyst Upgrades and Downgrades: AEP, Boeing, Dollar Tree, GE, Micron, NextEra, P&G, Roku, Snap, Starbucks, Tesla, Wynn and More – 24/7 Wall St.” with publication date: April 08, 2019.

The Clorox Company manufactures and markets consumer and professional products worldwide. The company has market cap of $19.62 billion. It operates through four divisions: Cleaning, Household, Lifestyle, and International. It has a 25.3 P/E ratio. The firm offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighters and color boosters; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning and disinfecting products under the Clorox, Dispatch, Aplicare, HealthLink, and Clorox Healthcare brands.

Investors sentiment increased to 0.88 in Q4 2018. Its up 0.02, from 0.86 in 2018Q3. It is positive, as 49 investors sold The Clorox Company shares while 259 reduced holdings. 83 funds opened positions while 187 raised stakes. 101.14 million shares or 5.58% more from 95.79 million shares in 2018Q3 were reported. Savant Cap Lc reported 1,826 shares or 0.06% of all its holdings. Cibc Ww Markets Inc holds 0% of its portfolio in The Clorox Company (NYSE:CLX) for 1,853 shares. Oakworth Cap Incorporated invested in 795 shares or 0.03% of the stock. 59,009 are held by Stevens L P. Marshall Wace Llp owns 18,281 shares. West Chester Advisors Inc owns 1,526 shares. Williams Jones And Associate Llc holds 0.01% or 2,085 shares in its portfolio. Planning Advsrs Ltd accumulated 2,370 shares or 0.13% of the stock. Brown Advisory Inc reported 9,869 shares. Dakota Wealth owns 10,826 shares for 0.37% of their portfolio. Connecticut-based Trexquant Investment Lp has invested 0.16% in The Clorox Company (NYSE:CLX). Segall Bryant Hamill Limited Liability Company reported 0.01% stake. Kayne Anderson Rudnick Investment Lc holds 34,633 shares or 0.04% of its portfolio. Burns J W Ny holds 0.59% or 13,552 shares in its portfolio. Td Cap Management Ltd Co stated it has 0% in The Clorox Company (NYSE:CLX).

The Clorox Company (NYSE:CLX) Institutional Positions Chart